
Axil Brands, Inc.
100
Recent news highlights include earnings fluctuations with Q3 earnings decline and margin compression due to higher costs, Q2 earnings growth driven by Walmart and retail expansion, and ongoing retail partnerships and market presence expansion.
- AXIL reported a year-over-year decline in Q3 earnings with shrinking margins attributed to higher costs [N4].
- The company announced a fall in Q3 income in early April 2026 [N5].
- In Q2, AXIL's earnings rose 29.7% year-over-year, supported by Walmart partnership and retail growth [N11].
- AXIL's Q2 profit climbed, reflecting improved revenues and profitability [N12].
- The company expanded its retail presence through partnerships with Walmart and planned availability at U.S. Marine Corps Exchange locations [N3].
- Multiple analyst blogs and reports have highlighted AXIL alongside other major companies in mid-2026 [N1][N2].
Axil Brands, Inc. is engaged in manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and marketing services. The company operates through three segments: hearing enhancement and protection, hair and skin care, and marketing services. The hearing enhancement and protection segment includes products such as Bluetooth-enabled earbuds, dual-mode in-ear devices, digital earbuds with touch control, and Bluetooth earmuffs with digital hearing protection technology. The hair and skin care segment offers professional-grade products under the Reviv3 Procare brand, including shampoos, conditioners, scalp treatments, styling aids, and skin health solutions. Sales channels include direct-to-consumer via company websites and third-party platforms, domestic and international distributors, professional salon partnerships, and retail stores including Walmart and U.S. Marine Corps Exchange locations. The company holds multiple patents and trademarks related to its products and operates primarily in the U.S. with growing international presence. Fiscal year 2026 revenue was approximately $30.8 million with net income of about $2.7 million. Liquidity ratios as of May 31, 2026, indicate a current ratio of 3.19 and cash ratio of 0.99. The company faces risks related to customer concentration, supplier dependence, inflationary pressures, supply chain disruptions, regulatory compliance, and maintaining effective internal controls [S1].
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Axil Brands, Inc. operates primarily in hearing enhancement and protection products, hair and skin care products, and marketing services. The hearing enhancement and protection segment accounted for the majority of revenue in fiscal 2026. The company expanded retail distribution including Walmart and U.S. Marine Corps Exchange locations. Fiscal 2026 revenue was approximately $30.8 million with net income near $2.7 million. Liquidity ratios indicate a current ratio of 3.19 and cash ratio of 0.99 as of May 31, 2026. Risks include customer concentration, supplier dependence, and regulatory compliance [S1].
Axil Brands has expanded its retail footprint significantly, including partnerships with Walmart and U.S. Marine Corps Exchange locations, which broaden market access. The company continues to invest in product innovation and expand its product lines in hearing enhancement and protection as well as hair and skin care. Its multi-channel sales strategy and growing international presence support revenue diversification. The company holds multiple patents and trademarks, which may help protect its technology and brand. Recent news indicates periods of earnings growth and retail expansion, reflecting operational progress [N1][N3][N4][N5][S1].
The company faces risks from customer concentration, with one customer accounting for 23% of net revenues, and supplier concentration, with a few vendors accounting for the majority of purchases. Inflationary pressures and supply chain disruptions could increase costs and compress margins, as seen in recent earnings declines. Regulatory compliance across multiple jurisdictions imposes operational burdens and costs. The company has a small employee base, increasing operational risk from key personnel loss. Competition from larger, better-resourced firms may limit market share and pricing power. Maintaining effective internal controls and securing additional capital if needed are ongoing challenges [S1][N4][N5].
Axil Brands' competitive advantages include brand recognition, product technology and innovation, product quality and safety, pricing, breadth of product lines, network of technology and content partners, access to third-party retailers, sales channels, distributors, retailers, OEM partners, and patent protection. The company holds three active U.S. patents and multiple trademarks, which provide some protection against competition. Its diversified sales channels, including direct-to-consumer, retail partnerships with major chains like Walmart, and military exchange locations, support market access. However, the company faces competition from larger firms with more diversified product lines and greater resources. Customer and supplier concentration risks also present challenges to its competitive position [S1].
• Customer Concentration: One customer accounted for 23% of consolidated net revenues in fiscal year 2026, creating risk if that customer reduces or ceases purchases.
• Supplier Dependence: A limited number of suppliers provide the majority of inventory, with one vendor accounting for 79% of purchases in the hearing segment and three vendors accounting for 91% in hair and skin care, posing supply chain risks.
• Inflation and Supply Chain Risks: Inflationary pressures, raw material cost increases, transportation delays, and trade restrictions could increase costs and compress margins.
• Regulatory Compliance: The company operates in multiple jurisdictions with evolving laws and regulations, which impose compliance costs and operational burdens.
• Key Personnel Risk: The company has a small number of employees and relies heavily on key executives; loss of these individuals could impair operations.
• Internal Controls and Capital Needs: Maintaining effective internal controls over financial reporting is required; failure could lead to financial misstatements and regulatory issues. Additional capital may be needed, which may not be available on favorable terms.
Business trends: Expansion of retail distribution channels including Walmart and military exchanges; product innovation in hearing protection and hair care segments; increasing direct-to-consumer and wholesale sales mix.
Execution milestones: Growth in retail store presence to approximately 6,000 stores; introduction of new products such as the CRX digital hearing protection platform; maintenance of intellectual property portfolio including patents and trademarks.
Key risks: Customer and supplier concentration risks; inflationary and supply chain pressures impacting margins; regulatory compliance complexities; reliance on a small number of key personnel and maintaining effective internal controls.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Axil Brands, Inc. manufactures, markets, sells, and distributes high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and marketing services [S1].
- The company operates through three segments: hearing enhancement and protection, hair and skin care, and marketing services, with hearing enhancement and protection accounting for approximately 96% of revenue for fiscal year 2026, hair and skin care about 4%, and marketing services less than 1% [S1].
- AXIL changed its name from Reviv3 Procare Company to Axil Brands, Inc. in February 2024 and uplisted to the NYSE American exchange [S1].
- The company operates on a fiscal year ending May 31 [S1].
- AXIL's hearing enhancement and protection products include Bluetooth-enabled earbuds, dual-mode in-ear devices, digital earbuds with touch control, and Bluetooth earmuffs with digital hearing protection technology [S1].
- The company holds three active U.S. patents, one pending patent application, five registered trademarks, and twelve pending trademark registrations related to its hearing enhancement and protection segment [S1].
- AXIL's hair and skin care segment offers professional-grade products under the Reviv3 Procare brand, including shampoos, conditioners, scalp treatments, styling aids, and skin health solutions, with eight products across sixteen SKUs [S1].
- Hair and skin care products are manufactured through third-party co-packers and partners [S1].
- Sales channels include direct-to-consumer via company websites and third-party platforms, domestic and international distributors, professional salon partnerships, and retail stores including Walmart and U.S. Marine Corps Exchange locations [S1].
- In fiscal year 2026, AXIL expanded its retail presence to approximately 6,000 stores, including about 1,250 Walmart stores, and planned availability at certain U.S. Marine Corps Exchange locations starting fiscal 2027 [S1].
- Approximately 65% of consolidated net revenues for fiscal year 2026 were direct-to-consumer, down from about 80% in fiscal year 2025, reflecting growth in retail and wholesale channels [S1].
- One customer accounted for 23% of consolidated net revenues in fiscal year 2026, indicating customer concentration risk [S1].
- AXIL relies on a limited number of suppliers, with one vendor accounting for 79% of purchases in the hearing enhancement and protection segment and three vendors accounting for 91% of purchases in the hair and skin care segment [S1].
- The company had thirteen full-time and two part-time employees as of May 31, 2026, all in the United States [S1].
- AXIL's fiscal year 2026 financials include revenue of approximately $30.8 million, net income of about $2.7 million, basic EPS of $0.40, and diluted EPS of $0.33 [S1].
- Liquidity ratios as of May 31, 2026, include a current ratio of 3.19 and a cash ratio of 0.99, with cash and equivalents of approximately $4.46 million and current liabilities of about $4.5 million [S1].
- The company faces risks related to customer concentration, supplier dependence, inflationary pressures, supply chain disruptions, regulatory compliance, and the need to maintain effective internal controls [S1].
- Recent news highlights include Q3 earnings decline year-over-year with margin compression due to higher costs, Q2 earnings rise year-over-year driven by Walmart and retail growth, and expanded retail partnerships [N3][N4][N5][N11][N12][N13][N14].
Generated 2026-08-18
- S1 | 2026-08-18 | 10-K
- S2 | 2026-04-08 | 10-Q
- N1 | 2026-06-15 | www.nasdaq.com | The Zacks Analyst Blog Highlights Costco, Lam Research, KLA, Blue Ridge and AXIL | https://www.nasdaq.com/articles/zacks-analyst-blog-highlights-costco-lam-research-kla-blue-ridge-and-axil
- N2 | 2026-06-12 | www.nasdaq.com | Top Analyst Reports for Costco, Lam Research & KLA | https://www.nasdaq.com/articles/top-analyst-reports-costco-lam-research-kla
- N3 | 2026-04-30 | www.nasdaq.com | Morning Market Movers: HCAI, FATN, ENVB, AKAN See Big Swings | https://www.nasdaq.com/articles/morning-market-movers-hcai-fatn-envb-akan-see-big-swings
- N4 | 2026-04-24 | www.nasdaq.com | AXIL Q3 Earnings Decline Y/Y, Margins Shrink on Higher Costs | https://www.nasdaq.com/articles/axil-q3-earnings-decline-y-y-margins-shrink-higher-costs
- N5 | 2026-04-08 | www.nasdaq.com | AXIL Brands Inc. Announces Fall In Q3 Income | https://www.nasdaq.com/articles/axil-brands-inc-announces-fall-q3-income
- N6 | 2026-02-11 | www.nasdaq.com | The Zacks Analyst Blog Highlights NVIDIA, Amazon.com, Regeneron, National Presto and AXIL | https://www.nasdaq.com/articles/zacks-analyst-blog-highlights-nvidia-amazoncom-regeneron-national-presto-and-axil
- N7 | 2026-02-10 | www.nasdaq.com | Top Stock Reports for NVIDIA, Amazon & Regeneron | https://www.nasdaq.com/articles/top-stock-reports-nvidia-amazon-regeneron
- N8 | 2026-01-29 | www.nasdaq.com | The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL | https://www.nasdaq.com/articles/zacks-analyst-blog-johnson-johnson-netflix-arista-networks-omega-and-axil
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


